Clinical Trial Update: The Effects of Allicor on Patients After Revascularization Treatment During a Year [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effects of Allicor in patients after revascularization over one year for atherosclerosis and peripheral arterial di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Peripheral Arterial Disease

Drugs mentioned

• Allicor

Snippet

Sponsor: Institute for Atherosclerosis Research, Russia | Conditions: Atherosclerosis, Peripheral Arterial Disease | Phase 4 | Status: UNKNOWN